Hey Guys, I came across this whilst doing some research yesterday. Looks promising, especially for our castration resistant brothers from the UK. cellcentric.com/press-relea... .
CellCentric raises $26 million to tak... - Advanced Prostate...
CellCentric raises $26 million to take first-in- class p300/CBP inhibitor into the clinic.
Written by
paulofaus
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Disappointed in the first visit to MO
Did you ever see a new doctor and come away with the feeling that you just didn’t ‘connect’?
I’m...
Las Vegas patient is the first in the world to receive prostate cancer drug ARV-110
ARV-110 very promising...
No survival benefit to debulking the prostate with radiation in first randomized clinical trial
This is very disappointing. It did not make any difference whether the patients were...
